Remarkably, KLRG-1+CD57+ CD4+ and CD8+ T cells from BC patients exhibited high expression of iRs previously associated with EM/EMRA phenotypes such as 2B4, CD160 and PD-1. This evidence concerns the gene KLRG1 and breast cancer.